TCGX Acquisition II (TCXB)


Market Price (11/5/2026): $10.43 | Market Cap: $135.1 MilSector: Financials | Industry: Multi-Sector Holdings

TCGX Acquisition II (TCXB)


Market Price (11/5/2026): $10.43
Market Cap: $135.1 Mil
Sector: Financials
Industry: Multi-Sector Holdings

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Low stock price volatility
Vol 12M is 23%

Weak multi-year price returns
2Y Excs Rtn is -36%, 3Y Excs Rtn is -88%

Key risks
TCXB key risks include [1] the failure to complete a business combination within its mandated timeframe, Show more.

0 Low stock price volatility
Vol 12M is 23%
1 Weak multi-year price returns
2Y Excs Rtn is -36%, 3Y Excs Rtn is -88%
2 Key risks
TCXB key risks include [1] the failure to complete a business combination within its mandated timeframe, Show more.

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 11/1/2026

TCGX Acquisition II (TCXB) stock has lost about 5% since it went public on 10/16/2026 because of the following key factors:

1. Initial post-IPO price correction following a strong debut. The stock opened on October 16, 2026, at $11.20, representing a 12% gain from its $10.00 IPO price. However, it subsequently saw a correction, closing at $10.86 on its debut day and further declining to approximately $10.26 by October 30, 2026. This retracement from an initial surge is common for new public offerings, especially for SPACs that often gravitate toward their initial trust value.

2. Absence of warrants in the offering structure. Unlike many other Special Purpose Acquisition Company (SPAC) initial public offerings, TCGX Acquisition II's deal did not include warrants for investors. This structural difference diverges from standard market practices where warrant coverage is common, potentially making the offering less attractive to certain investors seeking additional upside potential typically associated with SPAC warrants.

Show more
Updated on 11/1/2026

TCGX Acquisition II (TCXB) stock has lost about 5% since it went public on 10/16/2026 because of the following key factors:

1. Initial post-IPO price correction following a strong debut. The stock opened on October 16, 2026, at $11.20, representing a 12% gain from its $10.00 IPO price. However, it subsequently saw a correction, closing at $10.86 on its debut day and further declining to approximately $10.26 by October 30, 2026. This retracement from an initial surge is common for new public offerings, especially for SPACs that often gravitate toward their initial trust value.

2. Absence of warrants in the offering structure. Unlike many other Special Purpose Acquisition Company (SPAC) initial public offerings, TCGX Acquisition II's deal did not include warrants for investors. This structural difference diverges from standard market practices where warrant coverage is common, potentially making the offering less attractive to certain investors seeking additional upside potential typically associated with SPAC warrants.

3. Lack of an announced business combination target. As of early November 2026, TCGX Acquisition II, having only gone public in mid-October 2026, has not yet announced a definitive merger or acquisition target. The valuation of a SPAC is significantly tied to its ability to identify and successfully combine with a compelling private company. Without an announced target, investor enthusiasm may remain subdued, causing the stock to trade closer to or slightly below its initial offering price.

4. General cautious sentiment in the broader SPAC market. The SPAC market in 2026 has been characterized by "selectively constructive" investor sentiment, where capital is concentrating around sponsors with proven track records and sectors with durable growth drivers. Many de-SPAC companies from prior cycles continue to trade below their $10.00 IPO price, and October 2026 witnessed a moderation in overall SPAC IPO activity and lower capital raised compared to previous months. This broader market caution and increased investor scrutiny likely contributed to the downward pressure on newly listed SPACs, including TCXB.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

null
null

Market Drivers

7/31/2026 to 11/4/2026
ReturnCorrelation
TCXB  
Market (SPY)2.6%2.3%
Sector (XLF)4.0%49.0%

Fundamental Drivers

null
null

Market Drivers

4/30/2026 to 11/4/2026
ReturnCorrelation
TCXB  
Market (SPY)7.0%2.3%
Sector (XLF)14.0%49.0%

Fundamental Drivers

null
null

Market Drivers

10/31/2025 to 11/4/2026
ReturnCorrelation
TCXB  
Market (SPY)13.4%2.3%
Sector (XLF)14.4%49.0%

Fundamental Drivers

null
null

Market Drivers

10/31/2023 to 11/4/2026
ReturnCorrelation
TCXB  
Market (SPY)89.7%2.3%
Sector (XLF)91.0%49.0%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
TCXB Return------6%-6%
Peers Return0%2%-6%0%0%120%111%
S&P 500 Return27%-19%24%23%16%11%102%

Monthly Win Rates [3]
TCXB Win Rate-----50% 
Peers Win Rate50%38%42%0%0%23% 
S&P 500 Win Rate75%42%67%75%67%36% 

Max Drawdowns [4]
TCXB Max Drawdown------ 
Peers Max Drawdown0%-0%-9%0%0%-1% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: AVAC, CSCM, FLSC, IPHX, JONE.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 11/4/2026 (YTD)

How Low Can It Go

TCXB has limited trading history. Below is the Financials sector ETF (XLF) in its place.

EventXLFS&P 500
2025 US Tariff Shock
  % Loss-15.5%-18.8%
  % Gain to Breakeven18.4%23.1%
  Time to Breakeven80 days79 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-10.7%-9.5%
  % Gain to Breakeven12.0%10.5%
  Time to Breakeven26 days24 days
2023 SVB Regional Banking Crisis
  % Loss-16.1%-6.7%
  % Gain to Breakeven19.1%7.1%
  Time to Breakeven270 days31 days
2022 Inflation Shock & Fed Tightening
  % Loss-22.3%-24.5%
  % Gain to Breakeven28.6%32.4%
  Time to Breakeven467 days427 days
2020 COVID-19 Crash
  % Loss-42.8%-33.7%
  % Gain to Breakeven74.8%50.9%
  Time to Breakeven289 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-19.7%-19.2%
  % Gain to Breakeven24.5%23.8%
  Time to Breakeven123 days105 days

Compare to AVAC, CSCM, FLSC, IPHX, JONE

In The Past

State Street Financial Select Sector SPDR ETF's stock fell -15.5% during the 2025 US Tariff Shock. Such a loss loss requires a 18.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

TCXB has limited trading history. Below is the Financials sector ETF (XLF) in its place.

EventXLFS&P 500
2022 Inflation Shock & Fed Tightening
  % Loss-22.3%-24.5%
  % Gain to Breakeven28.6%32.4%
  Time to Breakeven467 days427 days
2020 COVID-19 Crash
  % Loss-42.8%-33.7%
  % Gain to Breakeven74.8%50.9%
  Time to Breakeven289 days140 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-21.4%-12.2%
  % Gain to Breakeven27.3%13.9%
  Time to Breakeven272 days62 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-26.1%-17.9%
  % Gain to Breakeven35.3%21.8%
  Time to Breakeven162 days123 days
2008-2009 Global Financial Crisis
  % Loss-78.3%-53.4%
  % Gain to Breakeven359.8%114.4%
  Time to Breakeven2329 days1085 days

Compare to AVAC, CSCM, FLSC, IPHX, JONE

In The Past

State Street Financial Select Sector SPDR ETF's stock fell -15.5% during the 2025 US Tariff Shock. Such a loss loss requires a 18.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About TCGX Acquisition II (TCXB)

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

  • Bank of America Corporation (BAC)
  • Citigroup Inc. (C)
  • White & Case LLP
  • Marcum LLP

AI Analysis | Feedback

Chen Yu, Chief Executive Officer and Director

Chen Yu is the founder and Managing Member of TCG Crossover (TCGX). He previously led TCGX Acquisition (TCGX), a SPAC that went public in August 2026 and targeted healthcare in Asia. Prior to founding TCGX in 2021, Dr. Yu spent sixteen years as a Managing Partner at Vivo Capital. He has extensive operating experience, having held leadership roles at both private and public companies, including serving as the COO of Sagent Pharmaceuticals and CBO of China KangHui; both companies went public and were subsequently acquired. Dr. Yu has led investments or served on the board of over a dozen private and public companies, and while at Vivo, he led investments in companies such as Zai Labs, RiverVision (acquired by Horizon), CRISPR Therapeutics, Intellia, Durata (acquired by Actavis), Trauson (acquired by Stryker), and Revolution Medicines.

Craig Skaling, Chief Financial Officer and Director

Craig Skaling serves as the CFO and COO of TCGX. He was also the CFO and Director of their previous SPAC, TCGX Acquisition (TCGX). Before joining TCGX, Mr. Skaling was the Director of Finance at Vetamer Capital, a registered investment advisor focused on public and private financial-technology companies. Prior to Vetamer, he was the Chief Operating Officer, Chief Financial Officer, and Chief Compliance Officer of Copernicus Capital, an SEC-registered equity long/short healthcare strategy, where he managed financial operations, firm compliance, and all non-investment aspects of the business.

Cariad Chester, Managing Partner (TCGX)

Cariad Chester is a Managing Partner at TCGX. He was promoted to this role as part of the initiation of TCGX Fund II, reflecting his significant contributions to the firm's foundation.

Giuliano Marostica, Managing Partner (TCGX)

Giuliano Marostica is a Managing Partner at TCGX. He was promoted to Partner as part of the initiation of TCGX Fund II, acknowledging his instrumental role in the firm.

AI Analysis | Feedback

TCGX Acquisition II (symbol: TCXB) is a blank check company, also known as a Special Purpose Acquisition Company (SPAC), that filed for an initial public offering (IPO) in September 2026. The company's primary objective is to effect a merger, amalgamation, share exchange, asset acquisition, or similar business combination with one or more businesses, specifically targeting the life sciences and medical technology sectors in Asia. As of the current date, TCGX Acquisition II has no operating business, revenue, or identified acquisition target. Based on its nature as a pre-acquisition SPAC, the key risks to TCGX Acquisition II's business are:

Failure to Complete a Business Combination Within the Required Timeframe

TCGX Acquisition II has a limited period, typically 24 months from the closing of its IPO, to complete a business combination. If the company fails to identify and consummate an initial business combination within this timeframe, it will be required to cease all operations except for the purpose of winding up, redeem all of its public shares, and liquidate. This would result in investors potentially losing the investment's opportunity cost and receiving back only their initial investment, without significant interest, or potentially less if there are liquidation expenses.

Inability to Identify a Suitable Acquisition Target

The success of TCGX Acquisition II hinges on its ability to identify and acquire a suitable target company in the highly competitive healthcare, life sciences, and medical technology sectors, particularly in Asia. There is no guarantee that the company will be able to identify an attractive target or successfully negotiate and complete a business combination. Competition from other SPACs, private equity firms, and strategic acquirers could make it challenging to find a desirable partner.

Risk of Shareholder Redemptions

Even if TCGX Acquisition II identifies a potential business combination, public shareholders have the right to redeem their shares in connection with the proposed merger. High redemption rates by public shareholders can significantly reduce the amount of cash available in the trust account, which may make it difficult to complete the business combination or fund the operations of the combined company post-acquisition. This could also lead to the termination of a proposed business combination if the remaining funds are insufficient.

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

Share Issuance

  • TCGX Acquisition II filed for an Initial Public Offering (IPO) in September 2026, planning to issue 10 million Class A ordinary shares at $10.00 per share to raise $100 million.
  • Concurrently with the IPO, TCGX Sponsor II, LLC agreed to purchase 450,000 Class A ordinary shares in a private placement for an aggregate of $4,500,000.
  • TCG Crossover Fund III committed to a forward purchase of at least $20 million, or 2 million shares, to close alongside any future business combination.

Inbound Investments

  • The company plans to raise $100 million through its Initial Public Offering.
  • TCGX Sponsor II, LLC will make an investment of $4.5 million through the purchase of private placement shares.
  • A forward purchase agreement outlines a commitment for at least $20 million from TCG Crossover Fund III upon completion of a business combination.

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

TCXBAVACCSCMFLSCIPHXJONEMedian
NameTCGX Acq.American.Crestone.Frazier .Inflecti.Jones Ve. 
Mkt Price10.43--10.209.829.8510.02
Mkt Cap-------
Rev LTM-------
Op Inc LTM-------
FCF LTM-------
FCF 3Y Avg-------
CFO LTM-------
CFO 3Y Avg-------

Growth & Margins

TCXBAVACCSCMFLSCIPHXJONEMedian
NameTCGX Acq.American.Crestone.Frazier .Inflecti.Jones Ve. 
Rev Chg LTM-------
Rev Chg 3Y Avg-------
Rev Chg Q-------
QoQ Delta Rev Chg LTM-------
Op Inc Chg LTM-------
Op Inc Chg 3Y Avg-------
Op Mgn LTM-------
Op Mgn 3Y Avg-------
QoQ Delta Op Mgn LTM-------
CFO/Rev LTM-------
CFO/Rev 3Y Avg-------
FCF/Rev LTM-------
FCF/Rev 3Y Avg-------

Valuation

TCXBAVACCSCMFLSCIPHXJONEMedian
NameTCGX Acq.American.Crestone.Frazier .Inflecti.Jones Ve. 
Mkt Cap-------
P/S-------
P/Op Inc-------
P/EBIT-------
P/E-------
P/CFO-------
Total Yield-------
Dividend Yield-------
FCF Yield 3Y Avg-------
D/E-------
Net D/E-------

Returns

TCXBAVACCSCMFLSCIPHXJONEMedian
NameTCGX Acq.American.Crestone.Frazier .Inflecti.Jones Ve. 
1M Rtn-4.0%---0.9%-1.2%0.4%-1.0%
3M Rtn-4.0%---0.9%-1.2%362.4%-1.0%
6M Rtn-4.0%---0.9%-1.2%362.4%-1.0%
12M Rtn-4.0%---0.9%-1.2%362.4%-1.0%
3Y Rtn-4.0%---0.9%-1.2%362.4%-1.0%
1M Excs Rtn-0.7%--2.3%2.6%3.6%2.5%
3M Excs Rtn-2.1%--1.0%0.6%364.3%0.8%
6M Excs Rtn-6.8%---3.6%-4.0%359.7%-3.8%
12M Excs Rtn-14.7%---11.3%-11.7%352.0%-11.5%
3Y Excs Rtn-87.4%---82.5%-82.9%280.6%-82.7%

Comparison Analyses

null

Financials

Price Behavior

Price Behavior
Market Price$10.20 
Distance from 52W High-6.1% 
   50 Days200 Days
DMA Price  
DMA Trend  
Distance from DMA  
 3M1YR
Volatility22.5%22.5%
Downside Capture  
Upside Capture  
Correlation (S&P 500)  
TCXB Betas & Captures as of 10/31/2026

 1M2M3M6M1Y3Y
Beta0.620.90-0.200.64-0.010.13
Up Beta7.872.820.282.150.790.59
Down Beta-0.51-0.210.020.31-0.20-0.26
Up Capture-88%-44%-27%-11%-4%-0%
Bmk +ve Days12182862130427
Stock +ve Days222222
Down Capture21%11%9%5%3%2%
Bmk -ve Days10253664121325
Stock -ve Days777777

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with TCXB
TCXB-7.0%23.2%-7.24-
Sector ETF (XLF)15.0%15.0%0.7139.2%
Equity (SPY)13.2%12.9%0.68-19.8%
Gold (GLD)1.0%28.8%0.03-0.0%
Commodities (DBC)35.9%21.2%1.347.4%
Real Estate (VNQ)14.3%14.1%0.7043.2%
Bitcoin (BTCUSD)-28.2%43.4%-0.656.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with TCXB
TCXB-1.4%23.2%-7.24-
Sector ETF (XLF)10.0%18.3%0.4039.2%
Equity (SPY)12.5%17.2%0.55-19.8%
Gold (GLD)17.3%19.1%0.73-0.0%
Commodities (DBC)8.0%19.6%0.297.4%
Real Estate (VNQ)1.8%18.9%-0.0143.2%
Bitcoin (BTCUSD)5.5%51.5%0.296.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with TCXB
TCXB-0.7%23.2%-7.24-
Sector ETF (XLF)13.7%22.1%0.5639.2%
Equity (SPY)15.4%18.0%0.73-19.8%
Gold (GLD)11.9%16.5%0.59-0.0%
Commodities (DBC)7.4%18.1%0.337.4%
Real Estate (VNQ)5.7%20.7%0.2343.2%
Bitcoin (BTCUSD)61.0%66.2%1.016.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Core Cache Last Updated: 11/4/2026